UBE Corporation · TSE:4208
UBE — FY2017 Earnings Presentation
34 slides from UBE's earnings presentation, May 10, 2018
Slide 1: FY2017 Consolidated Results, FY2018 Consolidated Forecasts
FY2017 Consolidated Results FY2018 Consolidated Forecasts May 10, 2018
Slide 2: Contents
Contents FY2017 Consolidated Results FY2018 Consolidated Forecasts Reference 2
Slide 3: FY2017 Consolidated Results
FY2017 Consolidated Results 3
Slide 4: Scope of Consolidation
FY2017 Consolidated Results Scope of Consolidation End of FY 2016 End of FY 2017 Difference Item Notes (A) (B) （B) - （A) Number of + UBE (Shanghai) LTD. consolidated 70 70 0 － Fukusei Tech Co.,Ltd subsidiaries Number of ＋ Changshu UM Battery Materials Co., Ltd. equity method 25 24 -1 － UBE (Shanghai
Slide 5: Environmental Factors: Naphtha Material Price
FY2017 Consolidated Results Environmental Factors FY 2016 FY 2017 Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 108.4 110.9 2.5 430 519 89 Naphtha CIF $/ｔ 34,500 42,000 7,500 Material Price Domestic Yen/KL Benzene(ACP) $/ｔ 723 826 103 Australian $/ｔ 80.7 104.6 23.9 Coal (CIF) Yen/t 8,748 11,
Slide 6: Major P/L Items
FY2017 Consolidated Results Major P/L Items (Billions of yen) FY 2016 FY 2017 Difference Percentage Item (A) (B) (B) - (A) change Net sales 616.5 695.5 79.0 12.8% Operating profit 34.9 50.2 15.2 43.7% Ordinary profit 33.3 50.7 17.3 52.1% Profit attributable to 24.1 31.6 7.4 31.0% owners of parent 6
Slide 7: Net Sales and Operating Profit by Segment
FY2017 Consolidated Results Net Sales and Operating Profit by Segment (Billions of yen) FY 2016 FY 2017 Difference Segment (A) (B) (B) - (A) Chemicals 258.3 305.4 47.0 10.9 10.2 -0.7 Net sales Pharmaceutical Cement & Construction Materials 227.2 238.8 11.6 Machinery 71.6 90.1 18.4 Energy & Environme
Slide 8: Analysis - Chemicals
FY2017 Consolidated Results Analysis - Chemicals (Billions of yen) Net Sales Difference of operating profit 400.0 Nylon/Caprolactam chain 18.3 Price ※1 10.8 +47.0 305.4 258.3 Synthetic rubber 11.0 合成ゴム 69.0 Battery Materials and Fine Chemicals 7.3 200.0 Polyimide and Specialty Products 5.1 Sales Vol
Slide 9: Analysis - Pharmaceutical
FY2017 Consolidated Results Analysis - Pharmaceutical (Billions of yen) Net Sales Difference of operating profit 12.0 10.9 -0.7 10.2 Price ※1 0.1 6.0 Sales Volume 1.2 0.0 -6.9% Decreased Fixed Cost 0.2 FY 2016 FY 2017 Operating profit Others ※2 -1.9 3.0 2.4 -0.3 2.1 Total -0.3 1.5 *1: Including both
Slide 10: Analysis – Cement & Construction Materials
FY2017 Consolidated Results Analysis – Cement & Construction Materials (Billions of yen) Net Sales Difference of operating profit 300.0 +11.6 Price ※1 -3.8 227.2 238.8 Cement and Ready-mixed concrete 9.9 69.0 Construction materials and 1.2 150.0 Limestone related products Sales Volume 1.1 etc -6 0 0
Slide 11: Analysis - Machinery
FY2017 Consolidated Results Analysis - Machinery (Billions of yen) Net Sales Difference of operating profit 100.0 +18.4 90.1 Price ※1 -0.2 71.6 69.0 50.0 Sales Volume 0.3 -6 0 0.0 25.8% Increased Fixed Cost -3.5 FY 2016 FY 2017 20.0 Operating profit Others ※2 5.2 6.0 +1.8 5.5 Total 1.8 3.6 3.0 *1: I
Slide 12: Analysis – Energy & Environment
FY2017 Consolidated Results Analysis – Energy & Environment (Billions of yen) Net Sales Difference of operating profit 80.0 +11.5 71.3 Price ※1 -0.4 59.7 Coal 10.2 69.0 Power 2.8 40.0 Sales Volume 0.7 etc -6 0 0.0 19.4% Increased Fixed Cost -0.2 FY 2016 FY 2017 20.0 Operating profit Others ※2 -0.6 3
Slide 13: Operating Profit – Net Income
FY2017 Consolidated Results Operating Profit – Net Income (Billions of yen) FY 2016 FY 2017 Difference Item (A) (B) (B) - (A) Operating profit 34.9 50.2 15.2 Non-operating income/expenses -1.6 0.4 2.0 Net Interests expenses -0.7 -0.1 0.5 Share of profit of entities accounted for using equtiy method
Slide 14: Consolidated Balance Sheet
FY2017 Consolidated Results Consolidated Balance Sheet (Billions of yen) End of FY 2016 End of FY 2017 Difference Item (A) (B) (B) - (A) Current assets 295.0 323.4 28.3 Fixed assets 414.2 419.5 5.3 Total assets 709.3 743.1 33.7 Interest-bearing debts 210.4 195.5 -14.9 Other liabilities 188.5 210.7 2
Slide 15: Consolidated Statements of Cash Flows
FY2017 Consolidated Results Consolidated Statements of Cash Flows (Billions of yen) Item FY 2016 FY 2017 Profit before income taxes 45.0 A.Cash flows from operating activities 53.4 73.3 Depreciation and amortization 35.3 Payment of Tax and others -9.2 etc. B.Cash flows from investing activities -40.
Slide 16: FY2018 Consolidated Forecasts
FY2018 Consolidated Forecasts 16
Slide 17: Scope of Consolidation
FY2018 Consolidated Forecasts Scope of Consolidation End of FY 2017 End of FY 2018 Difference Item Notes (A) (B) （B) - （A) Number of + Oita Ube *1 consolidated 70 70 0 － Ube Concrete Co., Ltd. subsidiaries Number of equity method 24 24 0 affiliates Total 94 94 0 *1: Tentative name 17
Slide 18: Environmental Factors: Naphtha Material Price
FY2018 Consolidated Forecasts Environmental Factors FY 2017 FY 2018 Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 110.9 110.0 -0.9 CIF $/ｔ 519 560 41 Naphtha Material Price Domestic Yen/KL 42,000 44,800 2,800 Benzene(ACP) $/ｔ 826 840 14 Australian $/ｔ 104.6 112.0 7.4 Coal (CIF) Yen/t 11,598
Slide 19: Major P/L & B/S Items
FY2018 Consolidated Forecasts Major P/L & B/S Items (Billions of yen) FY 2017 FY 2018 Difference Percentage Item change (A) (B) (B) - (A) Net sales 695.5 740.0 44.5 6.4% Operating profit 50.2 44.0 -6.2 -12.4% Ordinary profit 50.7 45.5 -5.2 -10.3% Profit attributable to 31.6 30.5 -1.1 -3.7% owners of
Slide 20: Net Sales and Operating Profit by Segment
FY2018 Consolidated Forecasts Net Sales and Operating Profit by Segment (Billions of yen) FY 2017 FY 2018 Difference Segment (A) (B) (B) - (A) Chemicals 305.4 320.0 14.6 10.2 10.0 -0.2 Net sales Pharmaceutical Cement & Construction Materials 238.8 250.0 11.2 Machinery 90.1 100.0 9.9 Energy & Environ
Slide 21: Analysis - Chemicals
FY2018 Consolidated Forecasts Analysis - Chemicals (Billions of yen) Net Sales Difference of operating profit Nylon/Caprolactam chain 5.6 305.4 +14.6 320.0 Price ※1 -10.7 300.0 Synthetic rubber 0.9 合成ゴム 69.0 Battery Materials and Fine Chemicals 3.0 Polyimide and Specialty Products 3.2 Sales Volume 8
Slide 22: Analysis - Pharmaceutical
FY2018 Consolidated Forecasts Analysis - Pharmaceutical (Billions of yen) Net Sales Difference of operating profit 12.0 10.2 -0.2 10.0 Price ※1 -0.6 6.0 Sales Volume -0.6 -2.0% Decreased 0.0 Fixed Cost -0.3 FY 2017 FY 2018 Operating Profit Others ※2 -0.1 2.1 -1.6 2.0 Total -1.6 1.0 *1: Including bot
Slide 23: Analysis – Cement & Construction Materials
FY2018 Consolidated Forecasts Analysis – Cement & Construction Materials (Billions of yen) Net Sales Difference of operating profit 300.0 +11.2 250.0 Cement and Ready-mixed concrete 5.2 Price ※1 0.7 238.8 Construction materials and 5.0 69.0 Limestone related products 150.0 etc Sales Volume 1.5 -6 0
Slide 24: Analysis – Machinery
FY2018 Consolidated Forecasts Analysis – Machinery (Billions of yen) Net Sales Difference of operating profit 120.0 +9.9 100.0 Price ※1 -0.2 90.1 69.0 60.0 Sales Volume 0.2 -6 0 11.0% Increased 0.0 Fixed Cost -1.1 FY 2017 FY 2018 20.0 Operating Profit Others ※2 1.6 8.0 +0.5 6.0 Total 5.5 0.5 4.0 *1:
Slide 25: Analysis – Energy & Environment
FY2018 Consolidated Forecasts Analysis – Energy & Environment (Billions of yen) Net Sales Difference of operating profit 100.0 +8.7 Price ※1 -0.2 80.0 71.3 Coal 7.0 69.0 Power 1.7 50.0 Sales Volume 0.2 -6 0 12.2% Increased 0.0 Fixed Cost 0.1 FY 2017 FY 2018 20.0 Operating Profit Others ※2 0.1 3.0 +0
Slide 26: Operating Profit – Net Income
FY2018 Consolidated Forecasts Operating Profit – Net Income (Billions of yen) FY 2017 FY 2018 Difference Item (A) (B) (B) - (A) Operating profit 50.2 44.0 -6.2 Non-operating income/expenses 0.4 1.5 1.1 Ordinaly profit 50.7 45.5 -5.2 Extraordinary income/losses -5.7 -3.0 2.7 Profit before income taxe
Slide 27: Reference
Reference 27
Slide 28: Changes in Results – Net Sales by Segments
Reference: FY2017 Consolidated Results Changes in Results – Net Sales by Segments (Billions of yen) FY 2017 Full-year Segment 1Q 2Q 3Q 4Q Total (forecast) Chemicals 73.3 72.9 79.0 80.0 305.4 295.0 Pharmaceutical 2.4 2.6 1.6 3.3 10.2 10.0 Cement & Construction 57.2 58.7 62.8 60.0 238.8 235.0 Material
Slide 29: Changes in Results – Operating Profit by Segments
Reference: FY2017 Consolidated Results Changes in Results – Operating Profit by Segments (Billions of yen) FY 2017 Full-year Segment 1Q 2Q 3Q 4Q Total (forecast) Chemicals 6.1 7.1 8.8 6.7 28.9 23.5 Pharmaceutical 0.7 0.8 -0.1 0.6 2.1 2.0 Cement & Construction 2.4 3.3 3.9 2.4 12.3 13.0 Materials Mach
Slide 30: Net Sales and Operating Profit in Half Years by Segment
Reference: FY2018 Consolidated Forecasts Net Sales and Operating Profit in Half Years by Segment （Billions of yen） Net Sales Operating profit Segment First Second First Second Total Total half half half half Chemicals 150.0 170.0 320.0 8.5 14.0 22.5 Pharmaceutical 4.0 6.0 10.0 0.0 0.5 0.5 Cement & C
Slide 31: Consolidated Key Indicators
Reference: FY2017 Consolidated Results Consolidated Key Indicators (Billions of yen) FY 2018 Item FY 2016 FY 2017 (forecast) Capital investment 44.0 40.3 40.0 Depreciation and amortization 34.4 35.3 37.0 R&D expenses 13.6 13.2 14.0 Adjusted operating income 37.8 55.1 50.5 Interest-bearing debt 210.4
Slide 32: Consolidated Major Subsidiaries
Reference: FY2017 Consolidated Results Consolidated Major Subsidiaries (Billions of yen) Net Difference of Sales operating Subsidiaries and Affiliates Business profit FY 2017 from FY 2016 UBE CHEMICALS (ASIA) PUBLIC CO., LTD Manufacture and sales of caprolactam, ammonium sulfate, and nylon 42.7 ↑ *2
Slide 33: Major Items for Capital Expenditure
Reference: FY2018 Consolidated Forecasts Major Items for Capital Expenditure Estimeated Segment Subject Place completion date Development consturuction in Isa, Japan FY 2018 Kanayamadai mining zone Cement & Construction Construct fourth waste plastics Isa, Japan FY 2018 Materials processing faciliti
Slide 34: Forward-looking statements notice
This presentation material contains forward-looking statements concerning UBEʼs future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently available.